The Patent Finder

Terms ending in 2035

Emory University

Every in-force patent on Emory University's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,585,915Polypeptide Hydrogels and Uses Related Thereto
In force
 · High confidence
Emory UniversityIn forceHigh confidence
US 9,840,693Polypeptide Hydrogels and Uses Related Thereto
In force
 · High confidence
Emory UniversityIn forceHigh confidence
US 9,673,030Computer Readable Storage Mediums, Methods and Systems for Normalizing Chemical Profiles in Biological or Medical Samples Detected by Mass Spectrometry
In force
 · High confidence
Emory UniversityIn forceHigh confidence
US 10,323,077Expression of Chimeric Polypeptide with Variable Lymphocyte Receptors on Immune Cells and Uses for Treating Cancer
In force
 · High confidence
Emory University and Children's Healthcare of Atlanta, Inc.In forceHigh confidence
US 10,286,084Compositions for the Inactivation of Virus Replication and Methods of Making and Using the Same
In force
 · High confidence
Emory UniversityIn forceHigh confidence
US 9,932,344Pyrazolo[1,5-a]pyrimidine-5,7-diamine Compounds as CDK Inhibitors and Their Therapeutic Use
In force
 · High confidence
IP2IPO Innovations LimitedIn forceHigh confidence
US 10,414,772Pyrazolo[1,5-a]pyrimidine-5,7-diamine Compounds as CDK Inhibitors and Their Therapeutic Use
In force
 · High confidence
IP2IPO Innovations LimitedIn forceHigh confidence
US 10,927,119Pyrazolo[1,5-a]pyrimidine-5,7-diamine Compounds as CDK Inhibitors and Their Therapeutic Use
In force
 · High confidence
IP2IPO Innovations LimitedIn forceHigh confidence
US 11,566,029Pyrazolo[1,5-a]pyrimidine-5,7-diamine Compounds as CDK Inhibitors and Their Therapeutic Use
In force
 · High confidence
IP2IPO Innovations LimitedIn forceHigh confidence
US 9,950,168Methods for Intracardiac Surgery and Intracardiac Delivery of Therapies and Devices
In force
 · High confidence
Emory UniversityIn forceHigh confidence
37 more term ends in 2035 · Pro
10 of 47 patents shown. Soonest term end first, then patent number.
Pro members see all 47.
Upgrade to Pro
42 of these are in force and held by Emory University.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited